Kevin Kalinsky - Concepedia

Author

Kevin Kalinsky

Columbia University Irving Medical Center ORCID

Also Known As

Anthony Elias, Frankie Ann Holmes, K Kalinsky, K. Kalinsky, K.M. Kalinsky, Kalinsky K, Kevin Kalinsky, Kevin M Kalinsky, Kevin M. Kalinsky, Valrie Jooste

220

Publications

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Emory University Columbia University Massachusetts General Hospital Memorial Sloan Kettering Cancer Center

About

Kevin Kalinsky is an author at Columbia University Irving Medical Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	39	1.6K
2	Health Sciences	8	8	412
3	Cell Biology	8	8	238
4	Public Health	6	6	221
5	Nursing	2	2	169

Kevin Kalinsky

Publications

Citations

H-Index

Page 1

	Year	Citations
Current Landscape of Immunotherapy in Breast Cancer Sylvia Adams, Margaret E. Gatti‐Mays, Kevin Kalinsky, JAMA Oncology	2019	401
Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer Nicholas C. Turner, Seock‐Ah Im, Cristina Saura, New England Journal of Medicine	2024	178
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer Heather Greenlee, Katherine D. Crew, Jillian L. Capodice, Breast Cancer Research and Treatment OncologyPain MedicineWeekly Electro-acupunctureNeuropathic PainTaxane-induced Peripheral Neuropathy	2016	123
Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancers Ruth Rodríguez‐Barrueco, Jiyang Yu, Laura Saucedo-Cuevas, Genes & Development Autocrine Il-6–jak2–stat3–calprotectin AxisBreast OncologySignaling PathwayMedicineImmunology	2015	118
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607) Kevin Kalinsky, Krista M. Rubin, Donald P. Lawrence, Cancer	2017	115
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors Dawn L. Hershman, Heather Greenlee, Danielle Awad, Breast Cancer Research and Treatment NursingBreast OncologyClinic-based Survivorship InterventionMedicineCancer Management	2013	111
Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated Tumor Kevin Kalinsky, Fangxin Hong, Carolyn K. McCourt, JAMA Oncology	2020	101
Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) &lt; 25: SWOG S1007 (RxPonder) Kevin Kalinsky, William E. Barlow, Funda Meric‐Bernstam, Cancer Research Breast OncologyCancer ManagementGynecologyGynecology OncologyEndocrine Oncology	2021	88
Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer Dawn L. Hershman, Catherine Richards, Kevin Kalinsky, Breast Cancer Research and Treatment Surgical OncologyPhysician VolumeHealth InsurancePost-operative CareOutcomes Research	2012	81
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer Kevin Kalinsky, Katherine D. Crew, Susan Refice, Cancer Investigation Surgical OncologyBreast OncologyCancer ManagementPathologyObesity	2014	79

Page 1